NeuroPathways Intervention for Brain Tumor Patients
NeuroPathways: An Information and Support Intervention for Patients With Malignant Brain Tumors
Massachusetts General Hospital
50 participants
Nov 7, 2023
INTERVENTIONAL
Conditions
Summary
This goal of this study is to test an information and support intervention for patients with malignant (or "high-grade") brain tumors. This study was developed to help patients cope after a brain tumor diagnosis. The main question this study aims to answer is whether this intervention (which includes access to an information guide and one-on-one coaching sessions) is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in the coaching sessions, use the guide as desired, and complete a small group of short surveys at three different points in time; some participants will be asked to share feedback via exit interviews.
Eligibility
Inclusion Criteria4
- Age ≥18
- Massachusetts General Hospital Cancer Center patient
- Within 6 weeks of diagnosis with a primary malignant brain tumor
- Able to speak and read in English
Exclusion Criteria2
- Inability to provide informed consent as assessed by the study team (e.g., due to neurological impairment such as severe cognitive impairment/dementia or moderate-to-severe receptive aphasia)
- Deemed inappropriate to approach by patient's oncologist or study PI
Interventions
Information guide and four one-on-one coaching sessions
Referral to cancer center supportive care services (e.g., social work) upon request from the patient, caregiver, or clinician
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05976490